Bicara Therapeutics
Previously, Sathish Hasige was global head of drug product development for AstraZeneca Biologics and CMC and the Operations team lead for multiple early and late-stage biologics at Medimmune, Hospira/Pfizer and AstraZeneca.
He earned his MS. and Ph.D. in Biochemistry from University of Mysore, India and Postdoctoral training from Vanderbilt University and University of Colorado.
This person is not in any teams
This person is not in any offices
Bicara Therapeutics
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of immunotherapy. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy.